GEORGE R BLUMENSCHEIN to Bone Neoplasms
This is a "connection" page, showing publications GEORGE R BLUMENSCHEIN has written about Bone Neoplasms.
Connection Strength
0.242
-
Phase II trial of single-agent foretinib (GSK1363089) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Invest New Drugs. 2013 Apr; 31(2):417-24.
Score: 0.168
-
Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid. Int J Dermatol. 2008 Mar; 47(3):276-9.
Score: 0.031
-
Osteoblastic metastatic disease as a therapeutic response to adjuvant chemotherapy in breast cancer. J Surg Oncol. 1983 May; 23(1):32-4.
Score: 0.022
-
Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone. Cancer. 1984 May 01; 53(9):1841-4.
Score: 0.006
-
Tamoxifen-induced hypercalcemia in breast cancer. Cancer. 1981 Jun 15; 47(12):2803-6.
Score: 0.005
-
Causes of death in breast cancer: a clinicopathologic study. Cancer. 1980 Jul 01; 46(1):162-7.
Score: 0.005
-
Combination chemotherapy of metastatic breast carcinoma with cyclophosphamide, adriamycin, and peptichemio. Cancer. 1984 May 01; 53(9):1836-40.
Score: 0.001
-
Complete remissions in metastatic breast cancer treated with combination drug therapy. Ann Intern Med. 1979 Dec; 91(6):847-52.
Score: 0.001
-
Spontaneous regression of breast carcinoma. Arch Intern Med. 1978 Nov; 138(11):1734-5.
Score: 0.001
-
Etiologic factors of hypercalcemia in breast cancer. Tex Med. 1978 Mar; 74(3):52-5.
Score: 0.001
-
Familial paraproteinemia. Arch Intern Med. 1971 Sep; 128(3):427-31.
Score: 0.001